Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/16/1991 | US5008247 Polysulfuric acid esters of bis-aldonamides and their derivatives, process for their preparation and medicaments |
04/16/1991 | US5008102 Biocompatible intraocular light-screening compositions and methods of intraocular light screening |
04/16/1991 | US5008038 As germicides and preservatives in cosmetics |
04/16/1991 | CA2001566A1 Medicaments |
04/16/1991 | CA1283250C Cyclohexanealkanoic acids |
04/16/1991 | CA1283122C Phenyl ethers |
04/16/1991 | CA1283119C Hydroxyacetic acid derivatives for the treatment of diabetic complications |
04/16/1991 | CA1283118C Hydroxypyrazole derivatives, their preparation and their use against microorganisms |
04/16/1991 | CA1283106C 3-amino-dihydropyridines, a process for their preparation, and their use in medicaments |
04/16/1991 | CA1283105C 1,4-dihydropyridines, processes for their preparation and their use in medicaments |
04/16/1991 | CA1283104C Trans-benzopyran-[4,3b]-1,4-oxazine derivatives |
04/16/1991 | CA1283103C Substituted 2,3-dihydro-6-hydroxy-pyrimido ¬2,1-f|-purine- 4,8(1h,9h)-diones |
04/16/1991 | CA1283098C Depolymerized hexosaminoglucan sulfates endowed with an antithrombotic, fibrinolytic, antiinflammatory activity, their process of preparation and related pharmaceutical compositions |
04/16/1991 | CA1283096C Antibacterial compounds |
04/16/1991 | CA1283055C Compositions to counter breath odor |
04/16/1991 | CA1283054C Antimycotic nail varnish |
04/16/1991 | CA1283053C Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
04/16/1991 | CA1283052C Medicament depot |
04/16/1991 | CA1283050C Anthraquinone drug composition and method |
04/16/1991 | CA1283049C Methods for suppressing the endocrine system |
04/16/1991 | CA1283047C Stabilized plasminogen activator precursor and method of producing the same |
04/16/1991 | CA1282994C Granular dietetic products based on amino acids and process for their preparation |
04/15/1991 | WO1991005783A1 Heterocyclic compounds |
04/14/1991 | WO1991005796A1 Carboxyalkyl dipeptide inhibitors of endopeptidases |
04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
04/14/1991 | CA2069312A1 Carboxyalkyl dipeptide inhibitors of endopeptidases |
04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
04/14/1991 | CA2027433A1 Collagen containing ophthalmic formulation |
04/14/1991 | CA2027325A1 6-substituted-1,2,3,4-tetrahydroisoquinolines |
04/14/1991 | CA2027315A1 Fibrinogen receptor antagonists |
04/14/1991 | CA2027169A1 Chemical compounds |
04/14/1991 | CA2027029A1 Oral compositions containing monoperoxy acids |
04/13/1991 | WO1991005791A1 Gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them |
04/13/1991 | WO1991005570A1 Radiation synovectomy compositions |
04/13/1991 | CA2067191A1 Gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them |
04/13/1991 | CA2027485A1 Process for the preparation of isoxazolyl, isothiazolyl, imidazobenzodiazepines, new derivatives obtained thereby, their use as drugs, and compositions containing these products |
04/13/1991 | CA2027204A1 Quinolonecarboxylic acid derivatives, process for their preparation and their use as antiviral agents |
04/13/1991 | CA2025314A1 Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels |
04/13/1991 | CA2000650A1 Product and process for the treatment and prevention of intravascular thrombi and atherosclerosis |
04/12/1991 | WO1991005784A1 Bicyclic pyrimidine derivative, method of producing the same, and pharmaceutical preparation containing the same as active ingredient |
04/12/1991 | WO1991005557A1 Use of antigestagens in the manufacture of medicaments |
04/12/1991 | CA2067173A1 Use of antigestagens for the production of pharmaceutical agents |
04/12/1991 | CA2027237A1 Tricyclic carbapenem compounds |
04/12/1991 | CA2027125A1 Renin inhibitors |
04/12/1991 | CA2026629A1 Heterocyclic compounds and production thereof |
04/11/1991 | WO1991005787A1 Iminomethanodibenzo(a,d)cycloheptene derivatives as neuroprotectant agents |
04/11/1991 | DE4029747A1 Psoriasis treatment |
04/11/1991 | DE3933738A1 Use of 2-amino:thiazole-derivs. in pharmaceutical products - for the redn. of thyroid-stimulating hormone levels in the blood |
04/11/1991 | DE3932338A1 Treatment of Alzheimer's disease by chelating aluminium - using electron-rich oxine derivs., e.g. ester(s) or urethane(s) or 8-hydroxy-quinoline or -quinaldine |
04/11/1991 | CA2067351A1 Neuroprotectant agents |
04/11/1991 | CA2027262A1 Phenethanolamine derivatives |
04/11/1991 | CA2027179A1 Chemical compounds |
04/11/1991 | CA2027076A1 Process for preparation of 4-(4-isobutylphenyl)-butyr-aldehyde and its use for the preparation of (-)-4(2-chlorophenyl)-2[2-(4-isobutylphenyl)-ethyl]-6,9-dim ethyl-6h-thieno[3,2-f]1,2,4]-triazolo[4,3][1,4]diazepine |
04/11/1991 | CA2026716A1 Polyether antibiotic |
04/11/1991 | CA2025661A1 Method of improving post-ischemic myocardial function using a thromboxane a antagonist in combination with a thrombolytic agent and combination |
04/10/1991 | WO1991004973A1 Indole derivatives, their preparation and use |
04/10/1991 | EP0421921A1 Double coated granules |
04/10/1991 | EP0421861A1 2-Hydroxy thiophene- and furan derivatives condensed with a nitrogen containing ring, process for their preparation and their therapeutical application |
04/10/1991 | EP0421829A1 Benzopyranone-beta-D-thioxylosides, method for their preparation and their use |
04/10/1991 | EP0421825A1 Paracetamol solutions |
04/10/1991 | EP0421819A1 Therapeutic nucleosides |
04/10/1991 | EP0421802A2 3-substituted-1,4-benzodiazepines useful as oxytocin antagonists |
04/10/1991 | EP0421777A1 Further antiviral pyrimidine nucleosides |
04/10/1991 | EP0421752A2 Substituted acrylamido-penicillanic acid derivatives |
04/10/1991 | EP0421751A2 Substituted acrylamido-penicillanic acid esters |
04/10/1991 | EP0421749A2 3-Aroyl-2-oxindole-1-carboxamides |
04/10/1991 | EP0421739A1 3'-azido purine nucleoside |
04/10/1991 | EP0421733A2 Amphotericin B lipid complex |
04/10/1991 | EP0421668A2 1,4-Dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents |
04/10/1991 | EP0421587A2 Xanthine derivatives used in asthma |
04/10/1991 | EP0421581A1 Chewable spray dried spheroidal microcapsules and wax coated microcapsules and methods for preparing same |
04/10/1991 | EP0421568A1 Macrolide compounds |
04/10/1991 | EP0421562A2 Use of prostacyclin analogs against metastases |
04/10/1991 | EP0421561A2 24-D-homo-vitamin D-derivatives, a process for their production, pharmaceutical compositions containing them and their use as medicines |
04/10/1991 | EP0421508A2 Sulphated glycosaminoglycuronan with antithrombotic activity |
04/10/1991 | EP0421456A2 Quinoline derivatives, their production and use |
04/10/1991 | EP0421454A2 Dressing containing estrogen |
04/10/1991 | EP0421436A2 Substituted carboxytetrahydroisoquinolines and derivatives thereof having pharmaceutical activity |
04/10/1991 | EP0421419A2 Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
04/10/1991 | EP0421365A2 Tetrazoleacetic acid derivatives having aldose reductase inhibitory activity |
04/10/1991 | EP0421364A2 Pleuromutilins |
04/10/1991 | EP0421333A1 Tretinoin emulsified cream formulations of improved stability |
04/10/1991 | EP0421297A2 Injectable preparations containing cephalosporin medicament and the use thereof |
04/10/1991 | EP0421210A2 Triazole compounds, their production and use |
04/10/1991 | EP0421208A2 Substituted 1,3,4-thiadiazolones, process for their preparation and their use for controlling endoparasites |
04/10/1991 | EP0421199A2 (+)-(2-Hydroxy)-2-adamantyl)-1-imidazolyl-3-tolyl-methane and its salts, process for its preparation, medicine containing this compound and its use |
04/10/1991 | EP0421110A1 Synergistic skin depigmentation composition |
04/10/1991 | EP0421079A2 Process for preparing acetylated derivatives of L-alpha-glycero-phosphoryl-serine with central nervous system activity |
04/10/1991 | EP0420953A1 8-beta-substituted ergolines, a process for manufacturing them, and their use |
04/10/1991 | EP0420942A1 Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
04/10/1991 | EP0420930A1 Method of synthesis and novel compounds for pharmaceutical uses |
04/10/1991 | EP0420914A1 Cosmetic and skin treatment compositions. |
04/10/1991 | EP0420871A1 Method and compositions for treatment of parkinsonism syndrome in mammals |
04/10/1991 | EP0420849A1 Use of sucralfate |
04/10/1991 | EP0165933B1 Treatment of animal diarrhoea |
04/10/1991 | CN1050545A Inhibitor of retroinfection viral protease |
04/10/1991 | CN1050544A Benzopyranone-beta-d-thioxylosides, their method of preparation and their use in therapy |
04/10/1991 | CN1050539A Biphenylmethane derivative and pharmacological use |
04/10/1991 | CN1050502A Topical preparation for treatment of aphthous ulcers and other lesions |
04/10/1991 | CN1050501A Injectable preparations containing cephalosporin medicament |